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Mechanisms for an abnormal radionuclide left 
ventricular ejection fraction response to 
exercise in patients with chronic, severe aortic 
regurgitation 
To clarify the mechanisms for an abnormal radionuclide left ventricular (LV) ejection fraction 
response to exercise in patients with chronic, severe aortic regurgitation (AR), we studied seven 
control patients and 21 patients with AR. We used exercise radionuclide angiography and 
catheterization of the right and left sides of the heart to obtain a calculation of LV chamber 
elastance. The control and AR groups had similar heart rates, systolic blood pressure responses 
to exercise, and exercise durations. In both patient groups, LV end-diastolic volume did not 
change with exercise. In contrast to the decrease in LV end-systolic volume (p < 0.05) and 
increase in LV ejection fraction (p < 0.01) in the control group, LV end-systolic volume in the 
patients with AR increased, resulting in little change in their LV ejection fraction. By stepwise 
multiple regression analysis, the radionuclide LV ejection fraction at peak exercise in patients 
with AR was determined by the LV chamber elastance, LV end-systolic volume, and stroke volume 
at peak exercise (cumulative r = 0.79, p < 0.02); the change in radionucllde LV ejection fraction 
from rest to peak exercise was determined by the corresponding change in systemic vascular 
resistance, regurgitant index, and LV end-diastolic and end-systolic volumes (cumulative r = 0.88, 
p < 0.02). These data demonstrate that in patients with AR, the radionuclide LV ejection fraction 
at peak exercise is principally determined by the cumulative effects of chronic, severe AR on LV 
systolic chamber performance, and the change in radionuclide LV ejection fraction from rest to 
peak exercise is principally established by peripheral vascular responses. (AM HEART J 
1992; 123:453.) 
Richard E. Stewart, MD, Milton D. Gross, MD, and Mark R.,Starling, MD. 
Ann Arbor, Mich. 
A noninvasive technique that could follow the se- 
quential changes in left ventricular (LV) size and 
performance in patients with chronic, severe aortic 
regurgitation (AR) who have minimal or no symp- 
toms and thus that could guide the selection of 
patients for cardiac catheterization and aortic valve 
replacement would be helpful. Exercise radionuclide 
angiography has been proposed for this purp0se.l It 
has been shown that this noninvasive technique can 
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quantitate the changes in LV size and performance 
between rest and peak exercise.2 Moreover, it has 
been suggested that this technique may be useful for 
identifying those who will have progression of their 
symptoms and who will need aortic valve replace- 
ment among patients with AR who have minimal or 
no symptoms.3 
The precise pathophysiologic mechanism respon- 
sible for an abnormal radionuclide LV ejection frac- 
tion response to exercise in these patients is, however, 
a controversial topic. 4-7 Some believe that an abnor- 
mal radionuclide LV ejection fraction response to 
exercise in patients with AR is related to loading 
conditions5 or the peripheral vascular changes that 
occur with exercise.6 In contrast, other investigators 
have suggested that the chronic effects of AR on LV 
systolic performance or contractility play an integral 
role in determining how the left ventricle responds to 
exercise.7 This investigation was designed to clarify 
the mechanisms for an abnormal radionuclide LV 
ejection fraction response to exercise in patients with 
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Table I. Baseline hemodynamic values 
Controls (n = 7) Aortic regurgitation (n = 21) p Value 
HR 71 zk 7 71 -t 8 N.S. 
SBP (mm Hg) 143 k 22 147 + 25 N.S. 
RAP (mm Hg) 7+3 
PCWP (mm Hg) - 12 -Ir 6 
LVEDP (mm Hg) 12 i 4 18 k 10 N.S. 
LVSP (mm Hg) 129 k 32 143 t 30 N.S. 
+dP/dt max (mm Hg/sec) 1377 i- 442 1239 f 327 N.S. 
E max (mm Q/ml) 4.94 k 1.14 1.82 k 1.24 <O.OOl 
HR, Heart rate; SLIP, systolic blood pressure; RAP, right atria1 pressure; PCWP, pulmonary capillary wedge pressure; LVEDP, left ventricular end-diastolic 
pressure; LVSP, left ventricular systolic pressure; +dP/dt max, maximum rate of change of LV pressure; E,,,, chamber elastance. 
chronic, severe AR and therefore to possibly lead to 
an understanding of why an abnormal response to 
exercise is predictive of symptomatic and hemody- 
namic deterioration. 
METHODS 
Patients. The patient population consisted of seven pa- 
tients in the control group and 21 patients with chronic, 
severe AR. The seven patients in the control group were 
men with an age range of 40 to 72 years (mean 56 * 10 
years). No patient in the control group had experienced a 
myocardial infarction, and all had normal findings on elec- 
trocardiograms, chest roentgenograms, and physical exam- 
inations. These patients had been referred for cardiac 
catheterizations so that their chest pain syndromes could 
be evaluated. They were all found to have normal coronary 
anatomy, LV volumes, ejection fractions, and wall motion. 
The patients with AR consisted of 20 men and one 
woman with an age range of 33 to 78 years (mean 56 f  14 
years). Four patients were in clinical class I, 11 were in class 
II, six were in class III, and no patient was in class IV. Thus 
the majority of patients with AR had minimal or no symp- 
toms. At the time of referral 14 patients had LV hypertro- 
phy on an electrocardiogram, and eight patients had cardi- 
omegaly on a chest radiograph. These patients had evi- 
dence on physical examination of moderate to severe AR. 
All patients had been referred so that the hemodynamic 
significance of their AR could be defined. All were found to 
have normal coronary anatomy, angiographic 3+ or 4+ AR, 
and no evidence of significant aortic stenosis (aortic valve 
gradient of 10 mm Hg or less). 
Protocol. All patients provided written informed con- 
sent on forms approved by the Institutional Review Boards 
at the University of Michigan or VA Medical Centers. All 
/3-adrenergic-blocking and calcium-channel-blocking 
agents, vasodilators, inotropic agents, diuretics, and ni- 
trates were discontinued 24 to 48 hours before the initia- 
tion of the studies. The day before the cardiac catheteriza- 
tion, each patient, using a braked bicycle ergometer, 
underwent a supine bicycle exercise radionuclide angio- 
gram. The work load was begun at 200 kilopond-meters 
(kpm) and was progressively increased in increments of 100 
kpm every 3 minutes to a symptom limit. Gated equilib- 
rium radionuclide angiograms were obtained at each pa- 
tient’s rest and peak exercise. On the following day a diag- 
nostic catheterization of the right and left sides of the heart 
documented resting intracardiac pressures, cardiac output, 
and normal coronary anatomy. Micromanometer LV pres- 
sures and radionuclide angiograms were then obtained un- 
der baseline conditions and after methoxamine or nitro- 
prusside infusions to achieve multiple additional loading 
conditions with right atria1 pacing to maintain heart rate 
c0nstant.s 
Radionuclide angiography. The gated equilibrium ra- 
dionuclide angiograms were acquired with the use of a Si- 
emens Basicam (Siemens Medical Systems Inc., Iselin, 
N.J.) fitted with a low-energy all-purpose collimator. All 
studies were obtained after in vivo red blood cell labeling 
with 30 mCi technetium 99m for 30 msec frames through- 
out the cardiac cycle for 250 cardiac cycles. Midway 
through each radionuclide acquisition, a 2 ml blood sample 
was drawn. The blood samples were later counted for 2 
minutes, and the time delay between acquisition and 
counting of the blood samples was recorded. At the 
completion of exercise or cardiac catheterization, distance 
measurements were obtained for each patient to determine 
the LV geometric center for attenuation correction. 
Attenuation-corrected radionuclide LV volumes were 
calculated frame by frame by use of background-sub- 
tracted, hand-drawn, region-of-interest count data; decay- 
corrected blood sample counts; and attenuation correction 
as previously validated in this laboratory.g Right ventric- 
ular end-diastolic and end-systolic counts were obtained by 
use of a modification of the method of Maddahi et al.1° We 
have used this method to calculate right ventricular (RV) 
volumes for comparison to those obtained from biplane 
contrast cineventriculography” and to calculate RV vol- 
umes and ejection fractions in patients with RV infarc- 
tion.12 We used these data to calculate LV regurgitant in- 
dex (RI) as RI = (LVEDC-LVESC)/(RVEDC-RVESC), 
where EDC represents end-diastolic counts at maximum 
ventricular volume and ESC represents end-systolic counts 
at minimum ventricular volume for the LV and RV from 
the hand-drawn regions of interest. 
Cardiac catheterization. After coronary arteriography 
and cineventriculography were performed in the control 
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Table II. Exercise hemodynamic values 
Controls (n = 7) Aortic regurgitation (n = 21) p Value 
Exercise duration (min) 
Peak HR 
Peak SBP (mm Hg) 
Rest LVEDV (ml) 
Peak LVEDV (ml) 
Rest LVESV (ml) 
Peak LVESV (ml) 
Rest LVEF (“C ) 
Peak LVEF (“0) 
Rest CO (L/min) 
Peak CO (L/min) 
Rest SV (ml) 
Peak SV (ml) 
Rest RI 
Peak RI 
Rest SVR (dynes/set-cm5) 
Peak SVR (dynes/set-cm5) 
12.6 k 4.0 
125 2 18 
203 iz 26 
151 f  41 
147 k 35 
69 t 24 
50 * 13* 
53 * 7 
63 t 7** 
5.8 + 1.7 
11.5 +- 2.5** 
81 f  18 
97 k 27 
1242 f 365 
824 k 183* 
12.0 zk 3.5 
127 k 20 
197 t 26 
303 t 183 
313 k 182 
165 + 112 
177 t 129 
50 t 11 
48 k 12 
5.6 f 1.6 
10.6 + 6.9** 
73 + 36 
92 k 58 
2.5 + 1.9 
2.1 * 1.1 
1870 * 889 

















HR, Heart rate: SBP, systolic blood pressure; LVESV, left ventricular end systolic volume; LVEF, left ventricular ejection fraction; CO, cardiac output; 
SV, effective stroke uolume; RI, regurgitant index; SVR, systemic uascular resistance. 
*p i 0.05 us rest values. 
**p < 0.01 us rest values 
group and additional ascending aortography was per- 
formed in the patients with AR, a bipolar pacing catheter 
was placed into the right atrium of each patient to main- 
tain heart rate constant, and a precalibrated microman- 
ometer catheter (Millar Instruments, Houston, Texas) was 
positioned to measure LV pressure. Hemodynamic record- 
ings were obtained with an Electronics for Medicine VR- 
12, (PPG Biomedical Systems, Lenexa, Kan.) or Micor 
physiologic recorder, (Micor, Inc. Allison Park, Pa.) at 100 
mm/set paper speed. They included the simultaneous re- 
cording of an electrocardiographic lead (II), micromanom- 
eter LV and aortic pressure, and the first derivative of LV 
pressure (dP/dt). These hemodynamic recordings were 
obtained for 10 to 20 cardiac cycles at the beginning, mid- 
dle, and end of each radionuclide acquisition. 
The LV pressure waveforms were averaged and the av- 
erage LV pressure waveforms were hand digitized with a 
Calcomp 9100 inductance-digitizing surface (resolution 
0.02 mm) (Calcomp, Anaheim, Calif.) interfaced to an IBM 
XT, (IBM Corp., Armonk, NY.) beginning at the peak of 
the R wave of the simultaneously recorded electrocardio- 
gram.8 This program yields instantaneous LV pressure and 
the first derivative of LV pressure, dP/dt, at a variable 
sampling frequency. Interpolation of these hand-digitized 
LV pressure data was then performed to obtain instanta- 
neous LV pressures that coincided with the midpoint of 
each radionuclide frame so that isochronal LV pressure and 
volume data were available for further analysis. 
Calculation of maximum time-varying elastance and 
other derived hemodynamic parameters. The microman- 
ometer LV pressures were matched to their corresponding 
radionuclide LV volumes for each loading condition and 
then plotted to obtain multiple pressure-volume loops. The 
LV maximum time-varying elastance (E,,,) was defined as 
the maximum slope obtained from the linear regression of 
isochronal pressure-volume data points from each pres- 
sure-volume loop. E, has been proposed as a relatively 
load-independent index of contractility.13 This is probably 
valid when E,,, is measured in the same heart after phar- 
macologic interventions, which either positively or nega- 
tively affect contractility.14, l5 However, when E,, is cal- 
culated in different hearts, it may be affected by several 
factors other than contractility.16v I7 Accordingly, in this 
investigation E,,, is used to represent net LV systolic 
chamber performance. 
Several hemodynamic parameters were calculated from 
the radionuclide data at rest and peak exercise. The 
“effective” LV stroke volume was calculated as 
SV = (LVEDV - LVESV)/RI, where EDV and ESV repre- 
sent radiohuclide LV end-diastolic and end-systolic vol- 
umes and RI represents LV regurgitant index. “Effective” 
is used in this context as that portion of the total LV stroke 
output that does not contribute to regurgitant volume and 
thus would be effectively perfusing the peripheral tissues. 
Cardiac output (CO) was then calculated as CO = 
SV X HR, where SV represents “effective” LV stroke vol- 
ume and HR represents heart rate. The systemic vascular 
resistance (SVR) was calculated as SVR = (mBP/CO) x 80 
dynes/set-cm5, where mBP represents mean brachial ar- 
tery pressure determined as diastolic blood pressure (BP) 
plus one third of (systolic BP - diastolic BP). 
Statistical analysis. All data are expressed as the 
mean + 1 SD. Nonpaired t tests were used to compare the 
rest and peak exercise and the change in hemodynamic pa- 
rameters from rest to peak exercise between the control 
patients and patients with AR. Paired t tests were used to 
compare the LV size and performance measures at rest and 
peak exercise within each patient group. Correlation ma- 
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l p < 0.05 “S Control 
** p < 0.01 “S Control 
Fig. 1. The average LV end-diastolic volumes (left panel), end-systolic volumes (center panel), and ejec- 
tion fractions (right panel) for the control groups (closed boxes) and the patients with chronic, severe AR 
(open boxes) are shown at rest and peak exercise. Significant differences between the rest and peak exer- 
cise values for the control and AR groups are noted. 
o- 0’ lY o- 
Rest Peak Rest Peak Rest Peak 
Exercise Exa cise Exacise 
Fig. 2. The average rest and peak exercise values for the control patients and patients with chronic, se- 
vere AR are shown for “effective” stroke volume (left panel), cardiac output (central panel), and systemic 
vascular resistance (right panel). The format is similar to Fig. 1, and significant differences are noted. 
trices and stepwise multiple regression analyses were then 
performed to determine those hemodynamic parameters 
that independently determine the peak exercise radionu- 
elide LV ejection fraction and the change in radionuclide 
LV ejection fraction from rest to peak exercise. A p value 
of 0.05 or less was considered significant. 
RESULTS 
Baseline hemodynamic data. At the time of cardiac 
catheterization, 10 patients with AR had angio- 
graphic +4 AR and the remaining 11 patients had +3 
AR. The heart rate averaged 71 + 7 beats/min and 
the right atria1 and pulmonary capillary wedge pres- 
sures averaged 7 + 3 and 12 k 6 mm Hg, respec- 
tively. The mean cardiac output was 5.6 rt_ 1.6 L/min. 
The micromanometer LV end-diastolic and end-sys- 
tolic pressures averaged 18 + 10 and 143 f 30 mm 
Hg, respectively, and the average (+> maximum 
dP/dt was 1239 + 327 mm Hglsec. The LV E,,, av- 
eraged 1.82 + 1.24 mm Hg/ml, and it was less than 
that in the control group (4.94 +- 1.14 mm Hg/ml, 
p < 0.001, Table I). 
Exercise hemodynamic data. The mean rest and 
peak exercise hemodynamic data for the control and 
AR groups are shown in Table II, and they are com- 
pared in Figs. 1 and 2. The average heart rate, systolic 
blood pressure, and pressure-rate product at rest and 
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Fig. 3. The relationship between the radionuclide LV ejection fraction at peak exercise and the 
corresponding peak exercise LVESV (upper left panel), LV chamber elastance (IS,,,, upper right panel), 
and “effective” stroke volume (lower left panel) are shown. The individual data points, regression lines, 
and correlation coefficients are noted. 
peak exercise in the control and AR groups did not 
differ significantly. Consequently, the changes in 
these values did not differ between the two patient 
groups. The average exercise duration in the two 
groups were similar. 
The LV end-diastolic and end-systolic volumes 
(LVEDV and LVESV, respectively) were larger in 
the AR group than in the control group, both at rest 
(p < 0.05 for both) and at peak exercise (p < 0.05 for 
both). The changes in LVEDV in the two patient 
groups were similar. In contrast, the changes in 
LVESV in the control group differed from those in 
the AR group because LVESV decreased in the con- 
trol group (p < 0.05 for both) and increased in the AR 
group. Consequently, although there was no differ- 
ence in LV ejection fraction at rest, it differed for 
each group at peak exercise (p < 0.01). This occurred 
because there was a significant increase in LV ejec- 
tion fraction (p < 0.01) in the control group, but 
there was no change in LV ejection fraction from rest 
to peak exercise in the AR group (Fig. 1). 
In the patients with AR the regurgitant index at 
rest averaged 2.5 f 1.9. It decreased slightly, but it 
was statistically unchanged, at peak exercise 
(2.1 + 1.1). Although the cardiac output was some- 
what less in the AR group than in the control group 
at rest, it did not differ significantly between the 
groups. In both patient groups, cardiac output in- 
creased significantly at peak exercise (p < 0.01 for 
control and p < 0.01 for AR). Consequently, the 
change in cardiac output was similar in both patient 
groups. The systemic vascular resistance was higher 
in the AR group than in the control group at rest 
(1870 -t 889 vs 1242 + 365 dynes-sec/cm5), and val- 
ues continued to differ at peak exercise (1426 -+ 966 
vs 824 f 183 dynes-sec/cm5). In the control patients 
there was a decrease in systemic vascular resistance 
from rest to peak exercise (p < 0.05), while there was 
a small but insignificant decrease in systemic vascu- 
lar resistance in the patients with AR (Fig. 2). 
Determinants of LV ejection fraction response to ex- 
ercise. To establish the determinants of the peak ex- 
ercise LV ejection fraction and the change in LV 
ejection fraction from rest to peak exercise, a corre- 
lation matrix was established for each radionuclide 
LV ejection fraction parameter. As shown in Fig. 3, 
the peak exercise radionuclide LV ejection fraction 
correlated with LVESV at peak exercise (r = -0.66, 
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Fig. 4. Similar to Fig. 3, the change in radionuclide LV ejection fraction from rest to peak exercise and 
the change in systemic vascular resistance (upper left panel), stroke volume (upper right panel), and 
LVESV (lower left panel) are shown. The individual data points, regression lines, and correlation coeffi- 
cients are n&ted. 
P < 0.011, Emax (r = 0.62, p < O.Ol), and “effective” 
stroke volume at peak exercise (r = 0.50, p < 0.05). 
As shown in Fig. 4, the change in LV ejection fraction 
from rest to peak exercise correlated with the change 
in systemic vascular resistance (r = -0.58, p < 0.021, 
“effective” stroke volume (r = 0.52, p < 0.05), and 
LVESV (r = -0.49, p < 0.05). The change in system- 
atic vascular resistance also correlated with the 
change in regurgitant index (r = 0.63, p < 0.01). 
To establish the independent determinants of the 
LV ejection fraction at peak exercise and the change 
in LV ejection fraction from rest to peak exercise, 
stepwise multiple regression analyses were per- 
formed. The LV ejection fraction at peak exercise was 
determined by E,,,, LVESV, and stroke volume at 
peak exercise (cumulative r = 0.74, p < 0.02). The 
change in LV ejection fraction from rest to peak ex- 
ercise was determined by the corresponding change 
in systemic vascular resistance, LV regurgitant in- 
dex, and LVEDV and LVESV (cumulative r = 0.88, 
p < 0.02). 
DISCUSSION 
Borer et al.’ originally observed that during exer- 
cise the radionuclide LV ejection fraction increased 
from 57% to 71% in their control group, whereas it 
decreased from 47 % to 38% in patients with AR who 
had symptoms, and it decreased from 62 % to 57 % in 
patients with AR who had no symptoms. He sug- 
gested that the radionuclide LV ejection fraction re- 
sponse to exercise might aid in the detection of LV 
dysfunction before symptoms and resting LV dys- 
function developed and therefore might prove useful 
for the sequential evaluation of LV performance in 
these patients. In patients with chronic, severe AR 
who have no symptoms, the radionuclide LV ejection 
fraction response to exercise has subsequently been 
proved useful for predicting the eventual develop- 
ment of symptoms and the need for aortic valve sur- 
gery.3 The mechanism for an abnormal radionuclide 
LV ejection fraction response to exercise has, how- 
ever, remained controversial. 
Schuler et all8 calculated the LV end-systolic 
pressure-volume relationship using radionuclide an- 
giography in nine patients in a control group and 14 
patients with AR, and compared it with the change 
in radionuclide LV ejection fraction from rest to peak 
exercise. In each patient with AR who had a normal 
LV end-systolic pressure-volume slope, the exercise 
LV ejection fraction increased six ejection fraction 
Volume 123 
Number 2 LV function in aortic regurgitation 459 
units, whereas those patients with a reduced end- 
systolic pressure-volume slope had a decrease in their 
LV ejection fraction of five ejection fraction units. 
Subsequently, Shen et a1.7 demonstrated that the 
change in radionuclide LV ejection fraction from rest 
to peak exercise in control and AR groups was 
linearly related to the slope of the LV end-systolic 
pressure-volume relationship. These investigators 
suggested that the change in radionuclide LV ejec- 
tion fraction from rest to peak exercise might be re- 
lated to the long-term effects of chronic, severe AR on 
LV contractile performance. 
In contrast to these observations, other investiga- 
tors have suggested that the radionuclide LV ejection 
fraction response to exercise in patients with AR may 
be determined by resting hemodynamic condi- 
tions.lgl 2o For example, Massie et all9 reported that 
the change in radionuclide LV ejection fraction from 
rest to peak exercise was inversely related to pulmo- 
nary capillary wedge pressure (P = -0.69, p < 0.01). 
In addition, Boucher et a120 noted that a peak exer- 
cise pulmonary capillary wedge pressure of 15 mm Hg 
or more identified patients with AR who had lower 
radionuclide LV ejection fractions (p < 0.01) and 
higher end-systolic volumes at peak exercise 
(p < O.Ol), compared to patients with AR who had 
more normal pulmonary capillary wedge pressures at 
peak exercise. Still other investigators have sug- 
gested that there is a relationship between the change 
in radionuclide LV ejection fraction from rest to peak 
exercise and LV stress2i and the change in LVESV,“z 
cardiac output,23 or systemic vascular resistance.6 An 
increase in the radionuclide LV ejection fraction in 
patients with AR might therefore be associated with 
a lower resting LV peak or end-systolic stress, a re- 
duction in systemic vascular resistance, regurgitant 
index, and LVESV, and an improvement in cardiac 
output with exercise. Consequently, several hemo- 
dynamic mechanisms may be operative in patients 
with chronic, severe AR in determining how the left 
ventricle responds to the stress of exercise. 
The data from the present investigation expands 
on these observations. It indicates that depending on 
whether the peak exercise LV ejection fraction or the 
change in LV ejection fraction from rest to peak ex- 
ercise is used to evaluate LV performance, the hemo- 
dynamic determinants of these measures may differ 
in patients with AR. Notably, the peak exercise radi- 
onuclide LV ejection fraction was principally related 
to LV chamber performance, but the change in LV 
ejection fraction from rest to peak exercise was 
related to the corresponding change in peripheral 
vascular responses (i.e., systemic vascular resistance) 
and the resultant change in regurgitant index and LV 
volumes. Consequently, these data suggest that LV 
chamber performance might be the principal deter- 
minant of the peak exercise radionuclide LV ejection 
fraction, and that the change in LV ejection fraction 
from rest to peak exercise might be more affected by 
the response of the peripheral vasculature to chronic, 
severe LV volume overload. 
Establishing the physiologic determinants of the 
peak exercise radionuclide LV ejection fraction or the 
change in LV ejection fraction from rest to peak ex- 
ercise is necessary to understand how these data 
might contribute to the selection of patients with AR 
for cardiac catheterization and possible aortic valve 
surgery. It has been suggested that there is a natural 
hemodynamic progression in patients with chronic, 
severe volume overload that manifests initially as 
compensated, eccentric LV hypertrophy followed by 
LV systolic dysfunction in the absence of myocardial 
dysfunction and, finally, by the supervention of my- 
ocardial dysfunction. z4 We have previously shown 
that LV chamber elastance, (i.e., E,,,) may be 
abnormal in patients with AR in the absence of my- 
ocardial dysfunction. In those patients with AR who 
have an abnormal E,,,, the LV volume-to-mass ra- 
tio was increased, suggesting that inadequate, eccen- 
tric LV hypertrophy had developed and that LV 
shape had been altered. 25 If the preload reserve of 
these patients is fully utilized, then an increase in LV 
load, whether it be induced pharmacologically or by 
exercise, might equate to either no change or a 
reduction in shortening, in comparison to patients 
with AR and normal E,, in whom these adaptive 
hemodynamic processes have presumably not been 
exhausted. Because the peak exercise radionuclide 
LV ejection fraction incorporates both the long-term 
effects of chronic, severe LV volume overload on my- 
ocardial performance and these other detrimental 
hemodynamic effects, it is not surprising that E,,, is 
a major determinant of the peak exercise radionu- 
elide LV ejection fraction. 
Our data would also suggest that each patient with 
AR who has a peak exercise LV ejection fraction of 
less than 50% has abnormal LV chamber perfor- 
mance. This might be especially important in pa- 
tients with AR who have no symptoms, in whom 
noninvasive techniques are commonly used to char- 
acterize sequential changes in LV systolic perfor- 
mance. Progression from a peak exercise LV ejection 
fraction of 50% or more to one that is less than 50% 
might be an early marker of those patients with AR 
who have progressed into a new hemodynamic phase 
in which LV chamber performance is impaired. 
Sequential changes in the peak exercise LV ejection 
fraction are particularly important, because an iso- 
lated peak exercise LV ejection fraction of less than 
50% may represent LV systolic dysfunction due to 
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the existence of inadequate, eccentric LV hypertro- 
phy and alterations of LV shape,22 myocardial dys- 
function7 or both. When these data are coupled with 
the recent observations of Siemienczuk et a1.,3 a he- 
modynamic explanation for the clinical and prognos- 
tic significance of an LV ejection fraction at peak ex- 
ercise of 50% or less in patients with AR who have 
minimal or no symptoms can be appreciated. 
The observation that the response of the periph- 
eral vasculature to exercise may be an important de- 
terminant of the change in LV ejection fraction from 
rest to peak exercise in patients with AR substanti- 
ates the observations of other investigators.1g-23 A 
reduction in systemic vascular resistance due to ex- 
ercise, as observed in this investigation, produced a 
corollary reduction in regurgitant index and there- 
fore a maintenance or improvement in LV ejection 
fraction from rest to peak exercise. The change in LV 
ejection fraction from rest to peak exercise appears to 
represent, therefore, the effects of chronic, severe 
volume overload on peripheral vascular adaptations. 
Recently, Borow et al. 26 demonstrated that resting 
myocardial performance and myocardial reserve may 
be preserved in the type I diabetic group whether or 
not they have a normal increase from rest to peak ex- 
ercise in radionuclide LV ejection fraction or if they 
have no change or a decrement in LV ejection frac- 
tion with exercise. Consequently, a change in radio- 
nuclide LV ejection fraction from rest to peak exer- 
cise in patients with AR should probably not be 
equated with the presence or absence of abnormal 
myocardial performance at rest or the adequacy of 
myocardial reserve, but whether or not maladaptions 
of the peripheral vasculature have developed with 
the duration of chronic, severe AR. These data add 
further support to the important influence of the du- 
ration of chronic, severe AR on exercise performance 
and functional outcome after aortic valve surgery re- 
ported by Bonow et a1.27 
In this investigation, we used supine bicycle exer- 
cise to assess the changes in radionuclide LV volumes 
and ejection fractions. The response of the LV ejec- 
tion fraction should be comparable whether upright 
or supine bicycle exercise is used.28 In general, the 
average response of the LVEDV and LVESV and LV 
ejection fractions in our patients with AR was com- 
parable to those previously reported by other inves- 
tigators ‘9 2, 5-7, 18-22,2g; that is, all of the control pa- 
tients demonstrated an appropriate increase in LV 
ejection fraction, while five of 21 patients with AR 
had an increase in LV ejection fraction. The remain- 
ing patients had either no change or a decrease in 
ejection fraction with exercise. The data in this 
investigation should therefore be comparable to pre- 
vious studies in which supine bicycle exercise was 
used to assess the LV ejection fraction response to 
exercise in patients with AR.5* 6 I92 22 
We also used radionuclide angiography to calculate 
multiple hemodynamic parameters at rest and dur- 
ing peak exercise to compare with the radionuclide 
LV ejection fraction response to exercise. We have 
demonstrated that LV volumes and ejection frac- 
tions can be obtained accurately with the use of an 
attenuation correction technique previously vali- 
dated in this laboratory.g Moreover, we employed a 
modification of the technique of Maddahi et al.‘O to 
obtain right ventricular end-diastolic and end-sys- 
tolic counts and ejection fraction. The LV regur- 
gitant index, “effective” LV stroke volume and car- 
diac output, and system vascular resistance were 
then calculated both at rest and peak exercise. 
Importantly, we have used this approach to calculate 
right ventricular volumes for comparison t,o biplane 
cineventriculographic right ventricular volumes”l 
and to diagnosis and assess therapy of right ventric- 
ular infarction.12 The term effective should be clar- 
ified. We defined effective LV stroke volume and 
cardiac output as the beat and minute output, 
respectively, used to perfuse the peripheral vascular 
tissues. Consequently, total LV stroke or cardiac 
output was decremented by the regurgitant volume 
to calculate these hemodynamic parameters. The 
cardiac output calculated on the day before cardiac 
catheterization with the use of this radionuclide ap- 
proach was similar to that obtained with the use of 
the thermodilution technique, suggesting that this 
approach should have provided reliable information 
about right and left ventricular performance, cardiac 
output, and systemic vascular resistance. 
In conclusion, the data in this investigation suggest 
that the radionuclide LV ejection fraction during 
peak exercise is most strongly affected by LV cham- 
ber performance, and that the change in LV ejection 
fraction from rest to peak exercise is principally de- 
termined by peripheral vascular responses and their 
resultant effects on regurgitant index and LV vol- 
umes. Consequently, because the peak exercise LV 
ejection fraction reflects LV chamber performance 
and it has been shown to predict symptomatic dete- 
rioration in patients with AR,3 it might be an appro- 
priate noninvasive exercise radionuclide parameter 
to follow for establishing the time period for invasive 
studies and possible aortic valve replacement. 
We appreciate the assistance of Christina Brown, BS, Janet 
Petrusha, RN, Jacqueline Anderson, and Jacqueline LeRoy in the 
preparation of this manuscript. 
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